Fingerprint
Dive into the research topics of 'Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: Recent clinically relevant findings from DRCR.net Protocol T'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: Recent clinically relevant findings from DRCR.net Protocol T
Sophie Cai, Neil M. Bressler
Research output: Contribution to journal › Review article › peer-review
56
Scopus
citations